JPRN-UMIN000022963招募中未知
Comparison of Dual Amoxicillin/Vonoprazan Therapy and Triple Vonoprazan/Amoxicillin/Clarithromycin or Metronidazole Therapy for H. Pylori Eradication - Comparison of Vonoprazan-based Dual and Triple Therapies for H. Pylori Eradication
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
On going
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients uninfected with H. pylori Patients who have ever failed in eradication more than two times. Patients from whom IC cannot be obtained Patients considered not eligible to the study
研究者
相似试验
已完成
4 期
Efficacy and Safety of Dual Therapy for Helicobacter Pylori EradicationHelicobacter Pylori InfectionNCT05469685Nanjing First Hospital, Nanjing Medical University914
已完成
3 期
Comparison of Vonoprazan-based Dual and Triple Therapies for H. Pylori EradicationGastritis Associated With Helicobacter PyloriNCT02827942Hamamatsu University112
Enrolling By Invitation
不适用
Triple Versus Quadruple Therapy for the Eradication of Helicobacter PyloriHelicobacter Pylori InfectionNCT06299605Shandong University375
招募中
2 期
VAS third-line eradication studyHelicobacter pylori infectionJPRN-jRCTs031190031Soichiro Sue68
招募中
不适用
Sequential therapy with vonoprazan, amoxicillin 7 days and vonoprazan, metronidazole, and sitafloxacin 7 days versus triple therapy with vonoprazan, amoxicillin, and metronidazole 7days for early age Helicobacter pylori infection: a multicentre, open-label, randomised trialHelicobacter pylori infectionJPRN-UMIN000032109Yokohama City University Hospital190